Answers are grounded in this paper and cite their sources.
From 1990 to 2001, numerous site- and phosphorylation state-specific antibodies have been developed and many are now commercially available. These antibodies have facilitated understanding of the cytoskeletal organization, signal transduction and transcriptional mechanisms as well as clinical diseases. This review is an attempt to cover all these aspects.
No takes yet. Share an insight, caveat, or question.
Nagata et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: